Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Renal Involvement in Patients with COVID-19 Pneumonia and Outcomes After Stem Cell Nebulization

View ORCID ProfileGina M. Torres Zambrano, View ORCID ProfileCarlos A. Villegas Valverde, View ORCID ProfileAntonio Bencomo Hernández, View ORCID ProfileLobna Abdel Hadi, View ORCID ProfileRene Antonio Rivero, View ORCID ProfileYendry Ventura Carmenate
doi: https://doi.org/10.1101/2020.12.16.20236877
Gina M. Torres Zambrano
1Conception and design, acquisition of data. Consultant Urologist at Abu Dhabi Stem Cell Center (ADSCC). Telephone number: +971 506439223. ;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gina M. Torres Zambrano
  • For correspondence: dr.torresz@gmail.com dr.torresz@gmail.com gina.zambrano@adscc.ae
Carlos A. Villegas Valverde
2Analysis and interpretation of data, statistical analysis. Researcher at the ADSCC Immunology Laboratory.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carlos A. Villegas Valverde
  • For correspondence: carlos.valverde@adscc.ae
Antonio Bencomo Hernández
3Analysis and interpretation of data. Head of the ADSCC Stem Cell Laboratory.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Antonio Bencomo Hernández
  • For correspondence: antonio.bencomo@adscc.ae
Lobna Abdel Hadi
4Acquisition of data. Researcher at ADSCC.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lobna Abdel Hadi
  • For correspondence: loubna.hadi@adscc.ae
Rene Antonio Rivero
5Head of ADSCC Scientific Committee.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rene Antonio Rivero
  • For correspondence: rene.rivero@adscc.ae
Yendry Ventura Carmenate
6ADSCC General Manager.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yendry Ventura Carmenate
  • For correspondence: yendry.ventura@adscc.ae
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background The COVID-19 pandemic presented an unprecedented challenge to identify effective drugs for prevention and treatment.

Objective To characterize acute renal injury (AKI) in patients with COVID-19 and their relation with clinical outcomes within the framework of the SENTAD COVID clinical trial at the Abu Dhabi Stem Cells Center.

Methods Abu Dhabi Stem Cell Center (ADSCC) proposed a prospective clinical trial nebulization treatment with autologous stem cells (Non-Hematopoietic Peripheral Blood Stem Cells (NHPBSC)), at Abu Dhabi hospitals.

Participants 20 treated patients were compared with 23 not treated patients. Both groups received COVID 19 standard treatment.

Outcomes After the results were collected, this study was created to determine the impact of the disease on the renal function and the efficacy of the therapy on patient’s outcomes.

Results One third of the critical patients studied suffered kidney failure. Patients in the treated group showed a favorable tendency to improve in contrast to those in the control group. Less patients from group A suffered from sepsis in comparison with the group B (25% vs 65%), HR=0.38, (95% Confidence Interval: 0.16 – 0.86), *p=0.0212. These results suggested a NNT=2.5. An improvement in lymphocyte count, CRP, and shorter hospital stay after treatment was evidenced, which led to less superinfection and sepsis in the treated group.

Conclusions The proposed anti-inflammatory effect of the stem cells, offers a great promise for managing the illness, emerging as a crucial adjuvant tool in promoting healing and early recovery in severe COVID-19 infections and other supportive treatments.

ARTICLE SUMMARY Our study had several strengths and limitation:

  • It was a randomized trial.

  • The treatment showed a positive result, providing evidence that this intervention is effective in routine practice.

  • We found fewer complications related to prolonged hospital stay in the treated group.

  • The is the small number of participants.

  • It was carried out in 4 different hospitals, each with different criteria for the selection of the initial empirical antimicrobials, which can cause multiple resistant germs.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT04473170

Funding Statement

This work was supported by ADSCC. This research had not received any other specific grant from any funding agency in the public, commercial or not-for-profit sectors.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Emirates Institutional Review Board for COVID-19 Research (Ref. ID: DOH/CVDC/2020/1172)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • All authors participated on the critical revision of the manuscript for important intellectual content

  • Mailing address: Street #31, Area Muroor Road, Building # C43, Al Murjan Tower, Apartment 107, Abu Dhabi, UAE.

  • Abu Dhabi Stem Cells Center (ADSCC) Ringgold ID: 580443.

Data Availability

Extra data is available by emailing dr.torresz{at}gmail.com.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted December 18, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Renal Involvement in Patients with COVID-19 Pneumonia and Outcomes After Stem Cell Nebulization
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Renal Involvement in Patients with COVID-19 Pneumonia and Outcomes After Stem Cell Nebulization
Gina M. Torres Zambrano, Carlos A. Villegas Valverde, Antonio Bencomo Hernández, Lobna Abdel Hadi, Rene Antonio Rivero, Yendry Ventura Carmenate
medRxiv 2020.12.16.20236877; doi: https://doi.org/10.1101/2020.12.16.20236877
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Renal Involvement in Patients with COVID-19 Pneumonia and Outcomes After Stem Cell Nebulization
Gina M. Torres Zambrano, Carlos A. Villegas Valverde, Antonio Bencomo Hernández, Lobna Abdel Hadi, Rene Antonio Rivero, Yendry Ventura Carmenate
medRxiv 2020.12.16.20236877; doi: https://doi.org/10.1101/2020.12.16.20236877

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (434)
  • Anesthesia (99)
  • Cardiovascular Medicine (948)
  • Dentistry and Oral Medicine (178)
  • Dermatology (109)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (420)
  • Epidemiology (8983)
  • Forensic Medicine (4)
  • Gastroenterology (420)
  • Genetic and Genomic Medicine (1953)
  • Geriatric Medicine (190)
  • Health Economics (401)
  • Health Informatics (1328)
  • Health Policy (659)
  • Health Systems and Quality Improvement (519)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10801)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1827)
  • Nursing (110)
  • Nutrition (272)
  • Obstetrics and Gynecology (353)
  • Occupational and Environmental Health (470)
  • Oncology (997)
  • Ophthalmology (297)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (579)
  • Pharmacology and Therapeutics (275)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1898)
  • Public and Global Health (4122)
  • Radiology and Imaging (675)
  • Rehabilitation Medicine and Physical Therapy (368)
  • Respiratory Medicine (548)
  • Rheumatology (224)
  • Sexual and Reproductive Health (190)
  • Sports Medicine (177)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (80)